Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
- 16 May 2000
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (11) , 5768-5772
Abstract
Cisplatin is an anticancer drug that has enjoyed remarkable success against testicular tumors, but dose limiting side-effects have limited its application against a broader range of cancers. Previous studies have shown that high-mobility group (HMG) domain proteins such as HMG1 sensitize cells to cisplatin by shielding its major DNA adducts from nucleotide excision repair. Estrogen treatment increases HMG1 mRNA levels in breast cancer MCF-7 cells. Herein, we describe that treatment of human cancer cells having steroid hormone receptors with the appropriate hormone, estrogen and/or progesterone, significantly increases the potency of cisplatin and its analogue carboplatin by causing the overexpression of HMG1. These findings suggest that the proper combination of these drugs, which are already approved by the Food and Drug Administration, could have potential benefit in treating tumors such as ovarian or breast that carry the hormone receptors.Keywords
This publication has 52 references indexed in Scilit:
- Preferential Platination of an Activated Cellular Promoter by cis-DiamminedichloroplatinumBiochemistry, 1999
- Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA‐transfected Human Lung Cancer CellsJapanese Journal of Cancer Research, 1999
- Estrogen Treatment Induces Elevated Expression of HMG1 in MCF-7 CellsExperimental Cell Research, 1998
- Human Testis-Determining Factor SRY Binds to the Major DNA Adduct of Cisplatin and a Putative Target Sequence with Comparable AffinitiesBiochemistry, 1998
- Structural studies of interactions between anticancer platinum drugs and DNAProgress in Biophysics and Molecular Biology, 1996
- The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeastMutation Research/DNA Repair, 1996
- DNA Adducts of cis-Diamminedichloroplatinum(II) and Its Trans Isomer Inhibit RNA Polymerase II Differentially in VivoBiochemistry, 1995
- Higher-order nucleoprotein complexes in transcription: analogies with site-specific recombinationCurrent Opinion in Cell Biology, 1995
- Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adductsBiochemistry, 1992
- Estrogen and Progesterone Receptor Analyses in More Than 4000 Human Breast Cancer Samples: A Study with Special Reference to Age at diagnosis and stability of analysesActa Oncologica, 1990